🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/2003 | 0,3531 USD |
| 03/09/2003 | 0,3531 USD |
| 20/08/2003 | 2,7443 USD |
| 04/06/2003 | 0,3435 USD |
| 05/03/2003 | 0,3435 USD |
| 04/12/2002 | 0,3435 USD |
| 04/09/2002 | 0,3435 USD |
| 05/06/2002 | 0,3340 USD |
| 06/03/2002 | 0,3340 USD |
| 05/12/2001 | 0,3340 USD |
| 30/08/2001 | 0,3340 USD |
| 31/05/2001 | 0,3244 USD |
| 07/03/2001 | 0,3244 USD |
| 06/12/2000 | 0,3244 USD |
| 30/08/2000 | 0,3244 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/11/1988 | 8,89 | 9,06 | 8,85 | 8,99 | +1,57% | 2,46% | 5.550.418 |
| 29/11/1988 | 8,73 | 8,89 | 8,71 | 8,85 | +0,91% | 2,05% | 3.472.234 |
| 28/11/1988 | 8,75 | 8,81 | 8,65 | 8,77 | +0,46% | 1,82% | 4.417.320 |
| 25/11/1988 | 8,75 | 8,79 | 8,71 | 8,73 | -1,57% | 0,91% | 2.071.267 |
| 23/11/1988 | 8,87 | 8,93 | 8,83 | 8,87 | +0,45% | 1,12% | 2.465.525 |
| 22/11/1988 | 8,83 | 8,91 | 8,75 | 8,83 | -0,45% | 1,80% | 3.436.392 |
| 21/11/1988 | 8,83 | 8,87 | 8,75 | 8,87 | -0,22% | 1,35% | 2.695.666 |
| 18/11/1988 | 8,81 | 8,91 | 8,75 | 8,89 | +1,82% | 1,81% | 4.790.198 |
| 17/11/1988 | 8,65 | 8,79 | 8,59 | 8,73 | +2,33% | 2,30% | 4.328.659 |
| 16/11/1988 | 8,79 | 8,79 | 8,51 | 8,53 | -2,72% | 3,17% | 7.906.531 |
| 15/11/1988 | 8,83 | 8,85 | 8,77 | 8,77 | -0,45% | 0,90% | 3.181.099 |
| 14/11/1988 | 8,97 | 8,97 | 8,67 | 8,81 | -1,12% | 3,33% | 6.034.594 |
| 11/11/1988 | 9,01 | 9,06 | 8,91 | 8,91 | -1,97% | 1,77% | 4.509.754 |
| 10/11/1988 | 9,10 | 9,12 | 9,01 | 9,08 | -0,44% | 1,31% | 2.686.862 |
| 09/11/1988 | 9,06 | 9,12 | 8,95 | 9,12 | -0,43% | 1,97% | 4.384.622 |
| 08/11/1988 | 9,18 | 9,20 | 9,10 | 9,16 | +0,22% | 1,08% | 2.790.614 |
| 07/11/1988 | 9,18 | 9,20 | 9,06 | 9,14 | -0,86% | 1,51% | 2.998.118 |
| 04/11/1988 | 9,28 | 9,46 | 9,22 | 9,22 | -1,49% | 2,57% | 4.413.547 |
| 03/11/1988 | 9,34 | 9,44 | 9,30 | 9,36 | -0,21% | 1,49% | 7.529.880 |
| 02/11/1988 | 9,14 | 9,40 | 9,10 | 9,38 | +3,06% | 3,26% | 8.117.808 |
| 01/11/1988 | 9,10 | 9,12 | 9,01 | 9,10 | +0,00% | 1,31% | 3.293.654 |
| 31/10/1988 | 9,08 | 9,12 | 9,03 | 9,10 | +0,22% | 1,09% | 3.420.043 |
| 28/10/1988 | 9,12 | 9,20 | 9,03 | 9,08 | -0,44% | 1,96% | 2.610.149 |
| 27/10/1988 | 9,10 | 9,14 | 8,95 | 9,12 | -0,86% | 2,18% | 5.798.794 |
| 26/10/1988 | 9,36 | 9,36 | 9,18 | 9,20 | -0,22% | 1,91% | 5.146.099 |
| 25/10/1988 | 9,28 | 9,30 | 9,18 | 9,22 | +0,00% | 1,28% | 2.065.608 |
| 24/10/1988 | 9,22 | 9,38 | 9,16 | 9,22 | +0,00% | 2,37% | 3.841.339 |
| 21/10/1988 | 9,14 | 9,22 | 9,10 | 9,22 | +0,22% | 1,30% | 6.751.426 |
| 20/10/1988 | 9,16 | 9,22 | 9,06 | 9,20 | +0,22% | 1,73% | 7.837.992 |
| 19/10/1988 | 9,28 | 9,30 | 9,08 | 9,18 | -0,43% | 2,35% | 5.566.766 |